Aurinia Pharmaceuticals
AUPH
#4611
Rank
$2.05 B
Marketcap
$15.62
Share price
2.02%
Change (1 day)
71.08%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): $84.06 Million USD

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are $0.26 Billion USD. In 2024 the company made an earning of $12.28 Million USD, an increase over its 2023 earnings that were of -$74.7 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) $84.06 M584.43%
2024 $12.28 M-116.44%
2023 -$74.7 Million-31.8%
2022 -$0.11 Billion-39.4%
2021 -$0.19 Billion61.9%
2020 -$0.12 Billion-9.73%
2019 -$0.13 Billion92.65%
2018 -$64.19 Million36.39%
2017 -$47.07 Million106.29%
2016 -$22.82 Million-15.4%
2015 -$26.97 Million65.84%
2014 -$16.26 Million129.82%
2013 -$7.08 Million-26.6%
2012 -$9.64 Million
2010 -$5.46 Million-39.22%
2009 -$8.98 Million-43.78%
2008 -$15.98 Million-53.19%
2007 -$34.13 Million42.97%
2006 -$23.87 Million-23.03%
2005 -$31.02 Million36.1%
2004 -$22.79 Million172.57%
2003 -$8.36 Million484.61%
2002 -$1.43 Million
2000 -$6.79 Million453.81%
1999 -$1.23 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
$5.14 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-$5.49 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-$22.13 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA